{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:48:39Z","timestamp":1792244919231,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ghir.2020.101356","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T20:38:08Z","timestamp":1600979888000},"page":"101356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Patients with acromegaly might not be at higher risk for dopamine agonist-induced impulse control disorders than those with prolactinomas"],"prefix":"10.1016","volume":"55","author":[{"given":"Hande Mefkure","family":"Ozkaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge Polat","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Durcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humeyra Rekali","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emir","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burc Cagri","family":"Poyraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Kadioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2020.101356_bb0005","series-title":"Rang and Dale\u2019s Pharmacology","author":"Rang","year":"2011"},{"key":"10.1016\/j.ghir.2020.101356_bb0010","doi-asserted-by":"crossref","DOI":"10.1007\/s40264-017-0590-6","article-title":"Dopamine agonists and impulse control disorders: a complex association","author":"Grall-Bronnec","year":"2018","journal-title":"Drug Saf."},{"key":"10.1016\/j.ghir.2020.101356_bb0015","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2010-2443","article-title":"Place of cabergoline in acromegaly: a meta-analysis","author":"Sandret","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2020.101356_bb0025","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/brain\/awp170","article-title":"At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists","volume":"132","author":"Birgit","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.ghir.2020.101356_bb0030","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR (Text Revision)","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.ghir.2020.101356_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/j.1360-0443.2010.03218.x","article-title":"Impulse control disorders in patients with Parkinson\u2019s disease receiving dopamine replacement therapy: evidence and implications for the addictions field","author":"Ambermoon","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.ghir.2020.101356_bb0040","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat Parkinson disease","author":"Dodd","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ghir.2020.101356_bb0045","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-018-1744-8","article-title":"Impulse control disorders in patients with prolactinoma receiving dopamine agonist therapy: a prospective study with 1 year follow-up","author":"Celik","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.ghir.2020.101356_bb0050","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2018-02202","article-title":"Dopamine agonist-induced impulse control disorders in patients with prolactinoma: a cross-sectional multicenter study","author":"Dogansen","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2020.101356_bb0055","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz076","article-title":"Impulse control disorders in dopamine agonist-treated hyperprolactinemia: prevalence and risk factors","volume":"105","author":"De Sousa","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2020.101356_bb0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12020-014-0206-1","article-title":"Cabergoline treatment in acromegaly: pros","volume":"46","author":"Marazuela","year":"2014","journal-title":"Endocrine."},{"key":"10.1016\/j.ghir.2020.101356_bb0070","doi-asserted-by":"crossref","DOI":"10.3233\/JPD-140366","article-title":"Clinical profile of compulsive sexual behaviour and paraphilia in Parkinson\u2019s disease","author":"Sachdeva","year":"2014","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ghir.2020.101356_bb0075","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ghir.2020.101356_bb0080","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1530\/EJE-08-0896","article-title":"Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with non-functioning pituitary adenomas and age- and gender-matched controls","volume":"160","author":"Sievers","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2020.101356_bb0085","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2020.101356_bb0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2020.101356_bb0095","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1210\/jc.2010-1048","article-title":"Pituitary incidentaloma: an endocrine society clin... [J Clin Endocrinol Metab. 2011]\u2013PubMed result","volume":"96","author":"Freda","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2020.101356_bb0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.psychres.2018.05.006","article-title":"Minnesota impulse disorders interview (MIDI): validation of a structured diagnostic clinical interview for impulse control disorders in an enriched community sample","volume":"265","author":"Chamberlain","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ghir.2020.101356_bb0105","series-title":"Klinik Psikofarmakoloji Bulteni","article-title":"Psychometric properties of the Turkish version of the Barratt impulsiveness scale-11","author":"G\u00fcle\u00e7","year":"2008"},{"key":"10.1016\/j.ghir.2020.101356_bb0110","first-page":"163","article-title":"Turkish version of the beck anxiety inventory: psychometric properties","volume":"12","author":"Ulusoy","year":"1998","journal-title":"J. Cog. Psychother. Int. Quart."},{"key":"10.1016\/j.ghir.2020.101356_bb0115","first-page":"3","article-title":"Beck depresyon envanteri\u2019nin ge\u00e7erli\u011fi \u00fczerine bir \u00e7al\u0131\u015fma","volume":"6","author":"Hisli","year":"1988","journal-title":"T\u00fcrk Psikoloji Dergisi"},{"key":"10.1016\/j.ghir.2020.101356_bb0120","article-title":"Belirti Tarama Listesi (SCL-90-R)\u2019nin Ge\u00e7erlilik ve G\u00fcvenirli\u011fi","year":"1991","journal-title":"T\u00fcrk Psikolojik Dan\u0131\u015fma ve Rehberlik Dergisi"},{"key":"10.1016\/j.ghir.2020.101356_bb0125","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses","volume":"41","author":"Erdfelder","year":"2009","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.ghir.2020.101356_bb0130","doi-asserted-by":"crossref","DOI":"10.3758\/BF03193146","article-title":"G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.ghir.2020.101356_bb0135","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/cen.12375","article-title":"Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study","volume":"80","author":"Bancos","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2020.101356_bb0140","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","article-title":"Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs","volume":"174","author":"Moore","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ghir.2020.101356_bb0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.parkreldis.2013.09.006","article-title":"Impulsive and compulsive behaviors among Danish patients with Parkinson\u2019s disease: prevalence, depression, and personality","volume":"20","author":"Callesen","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ghir.2020.101356_bb0150","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/NRL.0b013e31819f952b","article-title":"Compulsive behaviors in patients with Parkinson\u2019s disease","volume":"16","author":"Kenangil","year":"2010","journal-title":"Neurologist"},{"key":"10.1016\/j.ghir.2020.101356_bb0155","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.parkreldis.2013.03.004","article-title":"Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson\u2019s disease","volume":"19","author":"Valen\u00e7a","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ghir.2020.101356_bb0160","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.parkreldis.2014.05.014","article-title":"Impulse control and related disorders in Mexican Parkinson\u2019s disease patients","volume":"20","author":"Rodr\u00edguez-Violante","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ghir.2020.101356_bb0165","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1212\/WNL.0000000000005816","article-title":"Longitudinal analysis of impulse control disorders in Parkinson disease","volume":"91","author":"Corvol","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.ghir.2020.101356_bb0170","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s11102-013-0480-6","article-title":"Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study","volume":"17","author":"Barake","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.ghir.2020.101356_bb0175","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/00207450600588881","article-title":"Normative data and a short form of the Barratt impulsiveness scale","volume":"117","author":"Spinella","year":"2007","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.ghir.2020.101356_bb0180","doi-asserted-by":"crossref","DOI":"10.4274\/npa.y6296","article-title":"Barratt d\u00fcrt\u00fcsellik \u00f6l\u00e7e\u01e7i kisa formu (BIS-11-KF) T\u00fcrk\u00e7e uyarlama \u00e7ali\u015fmasi","author":"Tamam","year":"2013","journal-title":"Noropsikiyatri Arsivi"},{"key":"10.1016\/j.ghir.2020.101356_bb0185","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0269881106073109","article-title":"New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson\u2019s disease: the role of dopamine agonist treatment and age at motor symptoms onset","volume":"21","author":"Giladi","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ghir.2020.101356_bb0190","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/mds.25291","article-title":"Prospective cohort study of impulse control disorders in Parkinson\u2019s disease","volume":"28","author":"Bastiaens","year":"2013","journal-title":"Move. Dis.: Off. J. Move. Dis. Soc."},{"key":"10.1016\/j.ghir.2020.101356_bb0195","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fneur.2018.00330","article-title":"Impulse-control disorders in Parkinson\u2019s disease: a meta-analysis and review of case-control studies","volume":"9","author":"Molde","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ghir.2020.101356_bb0200","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12381","article-title":"Sex differences in impulsive and compulsive behaviors: a focus on drug addiction","author":"Fattore","year":"2016","journal-title":"Addict. Biol."},{"key":"10.1016\/j.ghir.2020.101356_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/bs.irn.2017.04.006","article-title":"Impulse control and related disorders in Parkinson\u2019s disease","author":"Weintraub","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.ghir.2020.101356_bb0210","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-015-0316-2","article-title":"DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson\u2019s disease patients","author":"Zainal Abidin","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ghir.2020.101356_bb0215","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1530\/EJE-12-0198","article-title":"Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas","volume":"167","author":"Athanasoulia","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2020.101356_bb0220","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000335996","article-title":"Distinct dopaminergic personality patterns in patients with prolactinomas: a comparison with nonfunctioning pituitary adenoma patients and age- and gender-matched controls","volume":"96","author":"Athanasoulia","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ghir.2020.101356_bb0225","doi-asserted-by":"crossref","DOI":"10.1159\/000012272","article-title":"Neuropsychiatry and pituitary disease: an overview","author":"Weitzner","year":"1998","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.ghir.2020.101356_bb0230","doi-asserted-by":"crossref","DOI":"10.1176\/jnp.17.2.159","article-title":"Apathy and pituitary disease: it has nothing to do with depression","author":"Weitzner","year":"2005","journal-title":"J. Neuropsychiat."},{"key":"10.1016\/j.ghir.2020.101356_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/hbm.20588","article-title":"A voxel-based morphometry study of frontal gray matter correlates of impulsivity","author":"Matsuo","year":"2009","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.ghir.2020.101356_bb0240","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fendo.2018.00391","article-title":"Personality traits and physical complaints in patients with acromegaly: a cross sectional multi-center study with analysis of influencing factors","volume":"9","author":"Zimmermann","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ghir.2020.101356_bb0245","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1517\/14740338.2016.1151493","article-title":"The safety of treatments for prolactinomas","volume":"15","author":"Auriemma","year":"2016","journal-title":"Expert Opin. Drug Saf."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637420300654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637420300654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:52:27Z","timestamp":1761087147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637420300654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":47,"alternative-id":["S1096637420300654"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2020.101356","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients with acromegaly might not be at higher risk for dopamine agonist-induced impulse control disorders than those with prolactinomas","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2020.101356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101356"}}